{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:03:21Z","timestamp":1767139401666,"version":"build-2238731810"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,3,8]],"date-time":"2014-03-08T00:00:00Z","timestamp":1394236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00120-013-3419-7","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T04:59:18Z","timestamp":1394081958000},"page":"524-530","source":"Crossref","is-referenced-by-count":3,"title":["Botulinumneurotoxin Typ\u00a0A bei neurogener Detrusor\u00fcberaktivit\u00e4t","Botulinum neurotoxin type\u00a0A in neurogenic detrusor overactivity"],"prefix":"10.1007","volume":"53","author":[{"name":"f\u00fcr den Arbeitskreis Neuro-Urologie der Deutschsprachigen Medizinischen Gesellschaft f\u00fcr Paraplegie (DMGP)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"B\u00f6thig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pannek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Domurath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,8]]},"reference":[{"key":"3419_CR1","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"Schurch","year":"2000","unstructured":"Schurch B, St\u00f6hrer M, Kramer G et al (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692\u2013697","journal-title":"J Urol"},{"key":"3419_CR2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","volume":"55","author":"Apostolidis","year":"2009","unstructured":"Apostolidis A, Dasgupta P, Denys P et al (2009) Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 55:100\u2013120","journal-title":"Eur Urol"},{"key":"3419_CR3","first-page":"470","volume":"80","author":"Fowler","year":"2009","unstructured":"Fowler CJ, Panicker JN, Drake M et al (2009) A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry 80:470\u2013477","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3419_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00120-007-1295-8","volume":"46","author":"Sievert","year":"2007","unstructured":"Sievert K-H, Bremer J, Burgd\u00f6rfer H et al (2007) Botulinumtoxin in der Therapie der neurogenen Hyperaktivit\u00e4t. Konsensuspapier zum Einsatz bei neurogenen Blasenfunktionsst\u00f6rungen. Urologe 46(3):293\u2013296","journal-title":"Urologe"},{"key":"3419_CR5","first-page":"7","volume":"15","author":"Madersbacher","year":"2008","unstructured":"Madersbacher H, Fink KG, Kiss H et al (2008) Konsensuspapier zur Anwendung von Botulinumtoxin Typ A (BoNT-A) bei neurogener Detrusor\u00fcberaktivit\u00e4t. F\u00fcr den Arbeitskreis Blasenfunktionsst\u00f6rungen der \u00d6sterreichischen Gesellschaft f\u00fcr Urologie (\u00d6GU). J Urol Urogyn\u00e4kol 15(2):7\u201311","journal-title":"J Urol Urogyn\u00e4kol"},{"key":"3419_CR6","unstructured":"MDK-Gemeinschaft (2008) Off-Label-Use. Hinweise zur Begutachtung zur internen Verwendung durch die MDK-Gutachter. SEG 6 Sozialmedizinische Expertengruppe \u201eArzneimittelversorgung\u201c der MDK-Gemeinschaft, Essen, Stand: 06.02.2008"},{"key":"3419_CR7","unstructured":"Committee for Medical Products for Human Use (CHMP) (2005) Guidelines on conduct of pharmacovigilance for medicines used by paediatric population. Doc. Ref. EMEA\/CHMP\/235910\/2005, CHMP, London, 27 July 2005. http:\/\/www.emea.eu.int"},{"key":"3419_CR8","first-page":"94","volume":"96","author":"Hart","year":"1994","unstructured":"Hart D (1994) Heilversuch, Entwicklung therapeutischer Strategien, klinische Pr\u00fcfung und Humanexperiment \u2013 Grunds\u00e4tze ihrer arzneimittel-, arzthaftungs- und berufsrechtlichen Beurteilung. MedR 96:94\u2013105","journal-title":"MedR"},{"key":"3419_CR9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","volume":"60","author":"Cruz","year":"2011","unstructured":"Cruz F, Herschorn S, Paliotta P et al (2011) Efficacy and safety of onabotulinumtoxina in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol 60(4):742\u2013750. doi:10.1016\/j.eururo.2011.07.002","journal-title":"Eur Urol"}],"updated-by":[{"DOI":"10.1007\/s00120-014-3630-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T00:00:00Z","timestamp":1409788800000}}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-013-3419-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-013-3419-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-013-3419-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:04:27Z","timestamp":1558595067000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-013-3419-7"}},"subtitle":["Konsensus des Arbeitskreises Neuro-Urologie der DMGP","Consensus paper of the Working Group Neuro-Urology of the DMGP"],"short-title":[],"issued":{"date-parts":[[2014,3,8]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["3419"],"URL":"https:\/\/doi.org\/10.1007\/s00120-013-3419-7","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,8]]}}}